What Animal Models Have Taught Us About the Safety and Efficacy of Bisphosphonates in Chronic Kidney Disease
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism
Link
http://link.springer.com/article/10.1007/s11914-017-0361-4/fulltext.html
Reference43 articles.
1. Russell RGG. Bisphosphonates: the first 40 years. Bone. 2011;49:2–19.
2. Troehler U, Bonjour J-P, Fleisch H. Renal secretion of diphosphonates in rats. Kidney Int. 1975;8:6–13.
3. Miller PD. The kidney and bisphosphonates. Bone. 2011;49:77–81.
4. Tamura K, Suzuki Y, Matsushita M, Fujii H, Miyaura C, Aizawa S, et al. Prevention of aortic calcification by etidronate in the renal failure rat model. Eur J Pharmacol. 2007;558:159–66.
5. • Moe SM, Chen NX, Newman CL, Gattone II VH, Organ JM, Chen X, et al. A comparison of calcium to zoledronic acid for improvement of cortical bone in an animal model of CKD. J Bone Miner Res. 2014;29:902–10. One of the few studies to examine effects of bisphosphonates on bone remodeling and mechanics in animals with compromised kidney function.
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current vision on mechanism of action of bisphosphonates. The effect of long-term administration of bisphosphonates on bone tissue (preclinical studies);Osteoporosis and Bone Diseases;2024-03-17
2. Pathophysiology of bone disease in chronic kidney disease: from basics to renal osteodystrophy and osteoporosis;Frontiers in Physiology;2023-06-05
3. Bisphosphonates and bone mineral density in patients with end-stage kidney disease and renal transplants: A 15-year single-centre experience;Bone Reports;2022-06
4. Diagnosis and management of osteoporosis in chronic kidney disease stages 4 to 5D: a call for a shift from nihilism to pragmatism;Osteoporosis International;2021-06-15
5. Bisphosphonates and Bone Mineral Density in Patients with End-Stage Kidney Disease: A 15-Year Single-Centre Experience;SSRN Electronic Journal;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3